The Anti-Ageing Guide
Laser Skin Rejuvenation: How FracRevive Renews Texture and Tone
FracRevive is Pink's fractional Q-Switched Nd:YAG treatment for skin texture, tone, and early-ageing concerns. Unlike CO2 fractional lasers, it works without ablation: photoacoustic energy reaches the dermis to stimulate collagen and clear surface pigmentation without the recovery time resurfacing requires. Safe across Fitzpatrick I to VI, including pigment-prone skin.
Not all fractional lasers do the same thing. The category splits into two fundamentally different mechanisms: ablative fractional (CO2 or Er:YAG surface resurfacing, which removes micro-columns of skin and requires a healing period) and non-ablative fractional, which treats within the skin rather than lifting off its surface. FracRevive is the second type: a fractional Q-Switched Nd:YAG treatment that treats the skin in a fine grid of microscopic points, reaching the dermis to stimulate collagen without lifting off the surface. Like microneedling, the fractional points can produce light pinpoint bleeding, with redness settling over a day or two. That distinction is the reason FracRevive has a different skin-type safety profile, a different result character, and a different patient population than CO2 fractional resurfacing. For where FracRevive sits in Pink's full anti-ageing treatment classification, see the non-surgical facelift guide.
What is fractional Q-Switched Nd:YAG, and how is it different from CO2 fractional laser?
The term "fractional laser" covers treatments that deliver energy in a fractionated pattern of micro-columns across the skin, leaving surrounding tissue untreated to support rapid recovery. That is where the similarity between CO2 fractional and Q-Switched Nd:YAG fractional ends.
CO2 fractional resurfacing works by ablating micro-columns of skin tissue. The heat is intense enough to vaporise the surface skin in those columns, triggering a significant wound-healing response. The result is substantial: CO2 fractional at clinically effective settings delivers meaningful surface improvement and collagen remodelling, and its results in skin resurfacing are well-documented. The trade-off is also substantial: the treated surface is an open wound, requiring days to over a week of recovery, and the thermal injury risk for darker Fitzpatrick types (FST IV through VI) is real, because the ablative heat can disrupt melanin production at the treated zones.
Fractional Q-Switched Nd:YAG (FracRevive's modality) is non-ablative. The Q-Switched Nd:YAG delivers very short, high-peak-power pulses through a fractional handpiece, treating the skin in a fine grid of microscopic points that reach the dermis and stimulate collagen, without lifting off the surface. Like microneedling, the fractional points can produce light pinpoint bleeding at the time, and recovery is short, usually a day or two of redness, far less than ablative CO2 or erbium. The skin-type safety profile extends fully across FST I through VI, including melanin-rich and pigment-prone skin, where ablative resurfacing carries a real pigmentation risk.
For clients who want skin quality improvement, texture refinement, and early-ageing collagen work without CO2-level downtime or without the Fitzpatrick IV-VI risk that ablative resurfacing carries, FracRevive occupies a genuine and distinct clinical position. It is not a weaker version of CO2. It is a different mechanism with a different application profile.
What does FracRevive treat?
Texture and pore refinement
Enlarged pores, rough texture, and uneven surface quality are the clearest applications for FracRevive. The fractional energy pattern reaches the dermal layer where collagen remodelling influences pore structure and skin density; as collagen rebuilds over the weeks and months following each session, the surface texture smooths and pore visibility reduces. This is the concern most early-intervention clients present with, and FracRevive addresses it without the downtime of resurfacing.
Early-ageing skin quality decline
The first signs of structural skin ageing (reduced firmness, loss of the subtle luminosity and density that characterises younger skin, early fine lines at the surface layer) respond to FracRevive's collagen-stimulating effect before they develop into the structural laxity that Fotona 4D is designed to address. FracRevive is the earlier-intervention tool in the anti-ageing toolkit: not yet structural laxity, but skin quality is changing and the client wants to address it at depth rather than topically.
Uneven tone and surface pigmentation
FracRevive's Q-Switched Nd:YAG energy also targets surface pigmentation: melanin at the skin's surface absorbs the Q-Switched Nd:YAG energy and is broken down, clearing uneven tone, mild sun-related pigmentation, and early age spots. For clients with texture and tone concerns together, FracRevive addresses both in the same treatment.
For deep pigmentation, melasma, or significant sun damage, the Pigmentation Guide covers the treatments that work on colour at depth. FracRevive's pigment-clearing capability is real, but deep or hormonal pigmentation requires the specialist Pigmentation Guide approach.
Post-acne texture
Post-inflammatory texture, mild acne scarring, and the residual rough skin quality that remains after active acne has resolved respond to FracRevive's fractional collagen stimulation. The fractional Q-Switched Nd:YAG energy in the scar tissue triggers remodelling at the dermal level that surface treatments do not reach.
Who is FracRevive suited for?
FST IV through VI, specifically. For clients with medium-to-darker skin tones, CO2 fractional resurfacing carries a real risk of post-inflammatory hyperpigmentation at the ablated zones. The Q-Switched Nd:YAG mechanism does not carry the same risk: it is non-ablative, does not lift off the surface, and has a well-established safety profile for melanin-rich skin. FracRevive is frequently the appropriate choice for FST IV-VI clients who want dermal-level skin quality work and cannot tolerate CO2.
Clients who need texture/tone improvement without ablative downtime. Busy schedules, professional circumstances, or simply the preference for no visible wound: FracRevive suits clients for whom CO2's recovery period is not an acceptable trade-off.
Early-intervention clients in their late twenties to forties. The sweet spot for FracRevive is the window before structural laxity develops into the Fotona 4D indication: when skin quality is declining, pores are more visible, and texture is changing, but the structural concern is not yet the dominant one.
Clients alongside a Fotona 4D course. FracRevive and Fotona 4D address different parts of the same picture. Fotona 4D handles structural laxity, tightening, and the inside-out collagen framework. FracRevive handles texture, tone, surface quality, and pore refinement. They are not alternatives; they are a clinical combination. See the next section.
How does FracRevive fit with Fotona 4D?
FracRevive runs on the StarWalker MaQX, the Q-Switched Nd:YAG platform Pink can also bring into the final step of an Advanced Fotona 4D. As a standalone, FracRevive concentrates on texture and tone as the primary clinical focus. Fotona 4D is the multi-stage protocol built for structural lifting. They are complementary treatments, not the same one.
For clients whose primary goal is structural laxity and lifting, Fotona 4D is the primary treatment, and FracRevive is available as an add-on for the texture/tone component of their concern. For clients whose primary goal is texture and skin quality without significant structural laxity, FracRevive as the standalone treatment is the more direct match.
The two sit on the same treatment continuum: FracRevive is the earlier-intervention, texture-focused modality; Fotona 4D is the structural-laxity modality. A clinician reading your skin at the free consultation can advise which is the right starting point, or whether the combination is the appropriate course.
Book your free consultation at Pink's Doncaster clinic.
What to expect: sessions, results, and downtime
Sessions: Most clients need three to five sessions in a course for texture and skin quality, spaced three to four weeks apart. The shorter spacing than Fotona 4D reflects the faster recovery cycle of non-ablative fractional treatment. Results are progressive; the clearest improvement is typically visible four to six weeks after the final session in a course.
During treatment: A warming or mild prickling sensation during the fractional passes. Most clients tolerate FracRevive comfortably without anaesthetic. A topical gel can be used if preferred.
After treatment: Because FracRevive is non-ablative, there is no lifted surface or crust. The fractional points can produce light pinpoint bleeding at the time, followed by mild redness and warmth for a day or two that fades fast. Recovery is much shorter than ablative CO2 or erbium resurfacing. Most clients return to normal activity quickly, with sun protection advised on treated areas.
Maintenance: One to two sessions per year after the initial course maintains the texture and tone result as the skin continues its natural ageing process.
Frequently Asked Questions
What is the difference between FracRevive and Fotona 4D?
FracRevive is a standalone fractional Q-Switched Nd:YAG treatment focused on skin texture, tone, and early-ageing skin quality. Fotona 4D is a four-stage protocol focused on structural laxity and full-face multi-depth collagen rebuilding. Pink can also use FracRevive as the final step of an Advanced Fotona 4D; as a standalone it concentrates on texture and tone rather than structural lifting.
Is FracRevive safe for darker skin?
Yes. FracRevive is non-ablative, and the Q-Switched Nd:YAG wavelength is long established in treating pigment, so it does not carry the post-inflammatory hyperpigmentation risk that ablative CO2 resurfacing poses for darker skin types.
How does FracRevive compare to CO2 fractional laser?
CO2 fractional ablates micro-columns of skin, triggering a wound-healing response that produces significant surface improvement but requires real recovery time and carries a pigmentation risk for darker skin types. FracRevive is non-ablative: Q-Switched Nd:YAG delivered fractionally, treating within the skin in a grid of micro-points. Like microneedling, it can produce light pinpoint bleeding with a day or two of redness, and it is safe across all Fitzpatrick types. FracRevive does not replace CO2 where deep ablative resurfacing is specifically needed; it serves the texture-and-quality indication with much less downtime.
How many sessions does FracRevive need?
Most clients need three to five sessions in a course spaced three to four weeks apart. Individual response varies by concern severity, skin type, and how deeply the texture or tone issue is embedded. Your clinician assesses your progress at each session and advises on the appropriate course length for your specific presentation.
Is there downtime after FracRevive?
Short. FracRevive is non-ablative, so there is no lifted surface or crust. Like microneedling, the fractional points can produce light pinpoint bleeding at the time, and redness settles over a day or two. The recovery is much shorter than ablative CO2 or erbium resurfacing. Sun protection on treated areas is recommended in the weeks following treatment.
Book Your Free Consultation
Pink's Doncaster clinic runs free first appointments by booking, with a clinician who assesses your skin type, concern, and whether FracRevive, Fotona 4D, or a combination is the right starting point.
Book your free consultation (opens in a new tab).
For the full Anti-Ageing range, see Pink's Anti-Ageing Hub.
